Evidence map›Paper›PMID 42416798›Full record

ArticleJournal of toxicologic pathology2026

INHAND: Non-proliferative and proliferative lesions of fish - Chapter 12. Fish skeletal and tooth.

Wes Baumgartner, Ute Bach, James Baily, Christine Ruehl-Fehlert, Stacey Fossey, Satoshi Furukawa, Yuki Kato, Victoria Laast, Emily Meseck, Heike Schmidt-Posthaus and 4 more

Abstract read
In one paragraph

Article in Journal of toxicologic pathology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Wes BaumgartnerUniversity of Illinois College of Veterinary Medicine, Urbana, IL, USA.
Ute BachBayer AG, Wuppertal, Germany.
James BailyCharles River Laboratories, Tranent, Scotland, United Kingdom.
Christine Ruehl-FehlertBayer AG, Wuppertal, Germany.
Stacey FosseyAbbvie, North Chicago, IL, USA.
Satoshi FurukawaNissan Chemical Corporation, Tokyo, Japan.
Yuki KatoSHIONOGI & Co., Ltd., Toyonaka, Osaka, Japan.
Victoria LaastLabCorp, Madison, WI, USA.
Emily MeseckNovartis Pharmaceuticals, Inc. East Hanover, NJ, USA.
Heike Schmidt-PosthausUniversity of Bern, Bern, Switzerland.
Helmut SegnerUniversity of Bern, Bern, Switzerland.
Shiva Kumar ShanmukhappaVertex Pharmaceuticals, Boston, MA, USA.
Jan SpitsbergenOregon State University, Corvallis, OR, USA.
Jeffrey WolfExperimental Pathology Laboratories, Sterling, VA, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID42416798
PMCPMC13340209

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.